P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds


Temaj G., Chichiarelli S., TELKOPARAN AKILLILAR P., Saha S., Nuhii N., Hadziselimovic R., ...More

Biochemical Pharmacology, vol.226, 2024 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Review
  • Volume: 226
  • Publication Date: 2024
  • Doi Number: 10.1016/j.bcp.2024.116332
  • Journal Name: Biochemical Pharmacology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, Chimica, EMBASE, Veterinary Science Database
  • Keywords: Cancer, Drugs, Nuclear stress, p53, p53 inhibitors, p53 mutation, Ribosome biogenesis
  • Gazi University Affiliated: Yes

Abstract

The tumor suppressor proteins are key transcription factors involved in the regulation of various cellular processes, such as apoptosis, DNA repair, cell cycle, senescence, and metabolism. The tumor suppressor protein p53 responds to different type of stress signaling, such as hypoxia, DNA damage, nutrient deprivation, oncogene activation, by activating or repressing the expression of different genes that target processes mentioned earlier. p53 has the ability to modulate the activity of many other proteins and signaling pathway through protein–protein interaction, post-translational modifications, or non-coding RNAs. In many cancers the p53 is found to be mutated or inactivated, resulting in the loss of its tumor suppressor function and acquisition of new oncogenic properties. The tumor suppressor protein p53 also plays a role in the development of other metabolic disorders such as diabetes, obesity, and fatty liver disease. In this review, we will summarize the current data and knowledge on the molecular mechanisms and the functions of p53 in different pathways and processes at the cellular level and discuss the its implications for human health and disease.